About Us
What motivates us?
Our technology
Strategic Path Forward
Investors
Investor Relations Home
Corporate Governance
Press Releases
Events and Presentations
Stock Information
Interactive Chart
SEC Filings
FAQs
Contact Us
Email Alerts
Twitter
LinkedIn
Press Releases
Home
Investors
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
OK
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
OK
Email Alerts
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Mar 19, 2021
Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results
Received FDA IDE Approval for Pivotal Study of C-Scan®
Mar 15, 2021
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
Company expects to commence U.S. pivotal trial in late 2021
Photos
1
Jan 27, 2021
Check-Cap Issues Letter to Shareholders
Photos
1
Nov 18, 2020
Check-Cap Reports Third Quarter 2020 Financial Results and Corporate Highlights
Photos
1
Aug 6, 2020
Check-Cap Reports Second Quarter 2020 Financial Results and Corporate Highlights
IDE submission to the FDA for C-Scan® planned for the end of 2020; Initiation of a U.S. pivotal study planned for 2021
Photos
1
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
23
»
Menu
